Use of the curcumin analog BHMC in the treatment of endothelial dysfunction and related disorders
The present invention relates to an analog of curcumin, 2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone (BHMC) or a pharmaceutically acceptable salt, solvate or derivative thereof, for use in treating, preventing or managing endothelial dysfunction and/or a disorder associated with endothelia...
| Main Authors: | , , , |
|---|---|
| Format: | Patent |
| Published: |
2012
|